Cargando…
Antiviral therapy in acute viral hepatitis B: why and when
Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. Infectious Agents and Cancer 2009, 4:2.
Autores principales: | Morelli, Giuseppe, Perrella, Alessandro, Sbreglia, Costanza, Bellopede, Pasquale, Riccio, Vincenzo, Monaco, Antonio, Perrella, Oreste |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672065/ https://www.ncbi.nlm.nih.gov/pubmed/19338663 http://dx.doi.org/10.1186/1750-9378-4-5 |
Ejemplares similares
-
Antiviral therapy in acute viral hepatitis B: why and when
por: Morelli, Giuseppe, et al.
Publicado: (2009) -
Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist
por: Nappi, A., et al.
Publicado: (2017) -
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
por: Buonaguro, Luigi, et al.
Publicado: (2008) -
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
por: Kondili, Loreta A., et al.
Publicado: (2018) -
Correction to ‘Viral hepatitis and liver cancer’
por: Ringelhan, Marc, et al.
Publicado: (2018)